| PRODUCT PROPERTIES |
| Alternative Name: | | Hexokinase D, Hexokinase type IV |
| Appearance: | | Colorless liquid |
| Host: | | Rabbit |
| Isotype: | | Rabbit IgG |
| Immunogen: | | Synthetic peptide selected from the C-terminal region of human GCK |
| Species reactivity: | | Human, Mouse
|
| Applications: | | ELISA, IHC, WB
|
| Purity Detail: | | Affinity Purified Antibody |
| Concentration: | | 0.25 mg/ml |
| Formulation: | | 100 µg (0.25 mg/ml) purified rabbit Ig polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. |
| Handling: | | Avoid freeze/thaw cycles. |
| Short Term Storage: | | +4°C |
| Long Term Storage: | | -20°C |
| Miscellaneous/General: | | Hexokinases phosphorylate glucose to produce glucose-6-phosphate, thus committing glucose to the glycolytic pathway. Alternative splicing of the gene for GCK results in three tissue-specific forms of glucokinase, one found in pancreatic islet beta cells and two found in liver. The protein localizes to the outer membrane of mitochondria. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. Mutations in the gene have been associated with non-insulin dependent diabetes mellitus (NIDDM), also called maturity onset diabetes of the young, type 2 (MODY2); mutations have also been associated with persistent hyperinsulinemic hypoglycemia of infancy (PHHI). |
| Background / Technical Information: | | For the Original Manufacturer's Data Sheet please click here.
Our product description may differ slightly from the Original Manufacturer's Data Sheet. |
|
|
|
United States
